MODULAR COMBINATION OF MEDICATION INFUSION AND ANALYTE MONITORING

• US 20080200897A1
• Filed: 02/15/2008
• Published: 08/21/2008
• Est. Priority Date: 02/19/2007
• Status: Active Grant

• Current Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories Incorporated)
• Inventors: Hoss, Udo, Stafford, Gary A., Tall, Susan C.
• Granted Patent: US 9,636,450 B2
• Time in Patent Office: Days
• US Class Current: 604/504
• CPC Class Codes: A61M 2005/14268 with a reusable and a disposable component
• CPC Class Codes: A61M 2005/1726 the body parameters being measured at, or proximate to, the infusion site
• CPC Class Codes: A61M 2205/3561 local, e.g. within room or hospital
• CPC Class Codes: A61M 2205/3592 using telemetric means, e.g. radio or optical transmission
• CPC Class Codes: A61M 5/14244 adapted to be carried by the patient, e.g. portable on the body
• CPC Class Codes: A61M 5/1452 pressurised by means of pistons
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00
• CPC Class Codes: A61M 5/365 Air detectors A61M5/1684 takes precedence; in extracorporeal blood circuits A61M1/3626

Abstract

Methods and systems for providing modular components in an integrated infusion device and analyte monitoring system where the components are independently replaceable are provided.

Claims

1. A modular system for providing integrated medication delivery and physiological condition monitoring, comprising:

a replaceable first modular component configured to deliver medication;

a replaceable second modular component configured to analyte level detection, where the second modular component is connectable to the first modular component to establish electrical contact with the first modular component; and

a third modular component connectable to the first modular component when the first modular component is disconnected from the second modular component;

wherein a substantially water tight seal is formed when the first and second modular components are connected or when the first and third modular components are connected.

2. The system of claim 1 wherein one of the first modular component and the second modular components is configured for replacement independent of the other component.

3. The system of claim 1 wherein the first modular component includes a connection port to couple to either one of the second modular component or the third modular component.

4. The system of claim 3 wherein the third modular component includes a cap configured to couple to the connection port of the first modular component.

5. The system of claim 1 wherein the third modular component includes a cap.

6. The system of claim 5 wherein the cap includes an end cap or a plug.

7. The system of claim 1 wherein the analyte includes glucose.

8. The system of claim 1 wherein the first modular component includes a low profile infusion device.

9. The system of claim 1 wherein the second modular component includes an analyte sensor.

10. The system of claim 1 wherein the first modular component is configured to deliver medication to a patient at a first location in the patient, and further, wherein the second modular component is configured to detect analyte level of the patient at a second location in the patient.

11. The system of claim 10 wherein the first and second locations are separated by a predetermined distance.

12. The system of claim 11 wherein the predetermined distance includes less than approximately 12 inches.

13. The system of claim 1 wherein the first modular component includes a reusable portion and a disposable portion, wherein either of the second or third modular components are connectable to the reusable portion of the first modular component.

14. The system of claim 13 wherein the disposable portion of the first modular component includes one or more of an infusion set or a reservoir containing the medication for delivery.

15. The system of claim 10 wherein the reusable portion of the first modular component includes a processing unit to control the operation of one or more of the first modular component or the second modular component.

16. The system of claim 1 including a communication unit disposed in one or more of the first modular component or the second modular component, the communication unit configured to transmit to or receive data from a remote location.

17. The system of claim 16 wherein the remote location includes one or more of a portable control unit, a computer terminal, a server terminal, a mobile telephone, or a personal digital assistant.

18. The system of claim 16 wherein the communication unit is configured to transmit one or more signals corresponding to a respective one or more analyte levels to the remote location.

19. The system of claim 16 wherein the communication unit is configured to receive a flow instruction command to control delivery of the medication.

20. The system of claim 16 wherein the communication unit is configured to wirelessly communicate over one or more of an RF communication link, a Bluetooth communication link, or an infrared communication link.

21. The system of claim 1 wherein the second modular component includes an inner wall and an outer wall, a plurality of electrodes disposed between the inner wall and the outer wall, and a fluid delivery channel formed by the inner wall.

22. The system of claim 21 wherein the plurality of electrodes comprise an analyte sensor.

23. A method, comprising:

positioning a replaceable first modular component on a skin surface of a user;

connecting a replaceable second modular component to a predetermined location on the first modular component during a first time period, wherein a water tight seal is formed between the first modular component and the second modular component;

connecting a third modular component to the predetermined location first modular component during a second time period, wherein a water tight seal is formed between the first modular component and the second modular component,

wherein the first time period and the second time period are nonoverlapping.

24. The method of claim 23 including:

delivering medication to the user; and

monitoring analyte level of the user.

25. The method of claim 23 wherein the analyte includes glucose.

26. A kit, comprising:

an infusion device configured to deliver medication, the infusion device including a port;

an analyte monitoring device configured to monitor an analyte level of a user, the analyte monitoring device connectable to the port of the infusion device during a first predetermined time period; and

a cap connectable to the port of the infusion device during a second predetermined time period;

wherein the first and second predetermined time periods are nonoverlapping.

27. The kit of claim 26 wherein the analyte includes glucose.

28. The kit of claim 26 wherein the infusion device includes an on-body patch pump.

29. The kit of claim 26 wherein the cap provides a water tight seal on the port when connected to the infusion device.

30. The kit of claim 26 wherein the analyte monitoring device provides a water tight seal on the port when connected to the infusion device.